This information is made available to consumers, both to empower Medicare beneficiaries and inform decision making, as well as to incentivize healthcare facilities to make continued improvements
Lawmakers in several states are considering legislation related to coverage of weight-loss drugs by state-regulated private health plans, Medicaid, state employee health plans, or some combination of those, or for studies to determine the feasibility of mandating such coverage
These differences become more pronounced in patients with baseline BMI above 35 or those with concurrent type 2 diabetes requiring robust glycemic control
However, the combined use of GLP-1RA and SGLT-2i may increase the total cost of medical care and potentially lead to a higher prevalence of medication-related adverse events [16, 17]
Burgmaier M, Heinrich C, Marx N
Crystal structure of the 2 adrenergic receptorG s protein complex